Prednisolone and Skin hypopigmentation - a phase IV clinical study of FDA data

Summary:

Skin hypopigmentation is reported as a side effect among people who take Prednisolone (prednisolone), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Envarsus Xr, and have Metastatic malignant melanoma.

The phase IV clinical study analyzes which people have Skin hypopigmentation when taking Prednisolone. It is created by eHealthMe based on reports of 211,370 people who have side effects when taking Prednisolone from the FDA, and is updated regularly.

What is Prednisolone?

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 212,675 Prednisolone users. Check the latest studies of Prednisolone.

What is Skin hypopigmentation?

Skin hypopigmentation (loss of skin colour) is found to be associated with 155 drugs and 286 conditions by eHealthMe. Check the latest studies of Skin hypopigmentation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

211,370 people reported to have side effects when taking Prednisolone.
Among them, 17 people (0.01%) have Skin hypopigmentation.

Could Prednisolone cause Skin hypopigmentation?

Among these 17 people:

How long have people been on Prednisolone when they have Skin hypopigmentation? *

What is the gender of people who have Skin hypopigmentation when taking Prednisolone? *

female: 56.25 %
male: 43.75 %

What is the age of people who have Skin hypopigmentation when taking Prednisolone? *

What are other drugs people take besides Prednisolone? *

What are other side effects people have besides Skin hypopigmentation? *

Rashes (redness): 6 people, 35.29%
Fever: 5 people, 29.41%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 4 people, 23.53%
Nausea And Vomiting: 3 people, 17.65%
Malignant Neoplasm Progression (cancer tumour came back): 3 people, 17.65%
Dyshidrotic Eczema (skin condition in which blisters develop on the soles of your feet and/or the palms of hands): 3 people, 17.65%
Vitiligo (pigment is lost from areas of the skin): 2 people, 11.76%
Joint Contracture (a permanent shortening of a muscle or joint): 2 people, 11.76%
Vision Blurred: 2 people, 11.76%
Hair Loss: 2 people, 11.76%

What are the existing conditions these people have? *

Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 4 people, 23.53%
Dyshidrotic Eczema (skin condition in which blisters develop on the soles of your feet and/or the palms of hands): 3 people, 17.65%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 11.76%
Transplant Rejection (a transplant material is not worked): 1 person, 5.88%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 5.88%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 1 person, 5.88%
Pemphigoid (tense blisters on the skin): 1 person, 5.88%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 1 person, 5.88%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisolone and have Skin hypopigmentation?

- Check whether Skin hypopigmentation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisolone:

Prednisolone (212,675 reports)

Browse all side effects of Prednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hypopigmentation:

Skin hypopigmentation (155 drugs)

Browse all the conditions that are associated with Skin hypopigmentation:

Skin hypopigmentation (286 conditions)

Related publications that referenced our studies

Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .
Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone (the active ingredients of Prednisolone) and Prednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.